RAPT Therapeutics Inc (NASDAQ: RAPT) on Tuesday, plunged -13.06% from the previous trading day, before settling in for the closing price of $1.05. Within the past 52 weeks, RAPT’s price has moved between $0.79 and $9.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -36.87%. The company achieved an average annual earnings per share of 81.30%. With a float of $68.90 million, this company’s outstanding shares have now reached $132.01 million.
Let’s determine the extent of company efficiency that accounts for 68 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
RAPT Therapeutics Inc (RAPT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of RAPT Therapeutics Inc is 47.81%, while institutional ownership is 45.19%.
RAPT Therapeutics Inc (RAPT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.80% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
RAPT Therapeutics Inc (RAPT) is currently performing well based on its current performance indicators. A quick ratio of 4.87 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Looking closely at RAPT Therapeutics Inc (NASDAQ: RAPT), its last 5-days average volume was 0.72 million, which is a drop from its year-to-date volume of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 7.07%. Additionally, its Average True Range was 0.12.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 8.07%, which indicates a significant increase from 2.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 122.27% in the past 14 days, which was lower than the 151.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1794, while its 200-day Moving Average is $1.8102. However, in the short run, RAPT Therapeutics Inc’s stock first resistance to watch stands at $1.0225. Second resistance stands at $1.1320. The third major resistance level sits at $1.1944. If the price goes on to break the first support level at $0.8506, it is likely to go to the next support level at $0.7882. Now, if the price goes above the second support level, the third support stands at $0.6787.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
Market capitalization of the company is 120.51 million based on 132,007K outstanding shares. Right now, sales total 0 K and income totals -129,870 K. The company made 0 K in profit during its latest quarter, and -53,250 K in sales during its previous quarter.
